96 related articles for article (PubMed ID: 18339256)
1. CYP1A1 gene polymorphism and polycystic ovary syndrome.
Esinler I; Aktas D; Otegen U; Alikasifoglu M; Yarali H; Tuncbilek E
Reprod Biomed Online; 2008 Mar; 16(3):356-60. PubMed ID: 18339256
[TBL] [Abstract][Full Text] [Related]
2. CYP1A1 polymorphism in adolescents with polycystic ovary syndrome.
Akgül S; Derman O; Alikaşifoğlu M; Aktaş D
Int J Gynaecol Obstet; 2011 Jan; 112(1):8-10. PubMed ID: 20965504
[TBL] [Abstract][Full Text] [Related]
3. CYP1A1 gene polymorphism and risk of epithelial ovarian neoplasm.
Aktas D; Guney I; Alikasifoglu M; Yüce K; Tuncbilek E; Ayhan A
Gynecol Oncol; 2002 Aug; 86(2):124-8. PubMed ID: 12144816
[TBL] [Abstract][Full Text] [Related]
4. Lack of an association between CYP1A1 gene Ile462Val polymorphism and polycystic ovary syndrome in Chinese.
Wang B; Wang J; Liu J; Ni F; Yan J; Zhou S; Mu Y; Cao Y; Ma X
Endocrine; 2009 Aug; 36(1):16-9. PubMed ID: 19507064
[TBL] [Abstract][Full Text] [Related]
5. CYP1A1 gene polymorphisms and polycystic ovary syndrome risk: a meta-analysis and meta-regression.
Shen W; Li T; Hu Y; Liu H; Song M
Genet Test Mol Biomarkers; 2013 Oct; 17(10):727-35. PubMed ID: 23848208
[TBL] [Abstract][Full Text] [Related]
6. CYP1A1 gene polymorphism and risk of endometrial hyperplasia and endometrial carcinoma.
Esinler I; Aktas D; Alikasifoglu M; Tuncbilek E; Ayhan A
Int J Gynecol Cancer; 2006; 16(3):1407-11. PubMed ID: 16803538
[TBL] [Abstract][Full Text] [Related]
7. Genetic polymorphisms of cytochrome P450 1A1 and risk of gallbladder cancer.
Tsuchiya Y; Sato T; Kiyohara C; Yoshida K; Ogoshi K; Nakamura K; Yamamoto M
J Exp Clin Cancer Res; 2002 Mar; 21(1):119-24. PubMed ID: 12071517
[TBL] [Abstract][Full Text] [Related]
8. Common polymorphisms in the CYP1A1 and CYP11A1 genes and polycystic ovary syndrome risk: a meta-analysis and meta-regression.
Shen W; Li T; Hu Y; Liu H; Song M
Arch Gynecol Obstet; 2014 Jan; 289(1):107-18. PubMed ID: 23852617
[TBL] [Abstract][Full Text] [Related]
9. CYP1A1 gene (6235TBayoumy N; El-Shabrawi M; Younes S; Atwa K
Hum Fertil (Camb); 2020 Jun; 23(2):142-147. PubMed ID: 30348034
[TBL] [Abstract][Full Text] [Related]
10. The effect of CYP1A1 and GSTM1 gene polymorphisms in bladder cancer development in a Turkish population.
Öztürk T; Kahraman ÖT; Toptaş B; Kisakesen Hİ; Çakalir C; Verim L; Öztürk O; İsbir T
In Vivo; 2011; 25(4):663-8. PubMed ID: 21709011
[TBL] [Abstract][Full Text] [Related]
11. Pleomorphic (giant and/or spindle cell) carcinoma of lung shows a high percentage of variant CYP1A12.
Przygodzki RM; Koss MN; O'Leary TJ
Mol Diagn; 2001 Jun; 6(2):109-15. PubMed ID: 11468695
[TBL] [Abstract][Full Text] [Related]
12. [Study on the association of cytochrome P450 polymorphisms and the risk of esophageal cancer: a meta-analysis].
Dai LP; Wang YP; Wu XB; Wang KJ; Lv QJ
Zhonghua Liu Xing Bing Xue Za Zhi; 2009 Nov; 30(11):1198-202. PubMed ID: 20193595
[TBL] [Abstract][Full Text] [Related]
13. Effects of cytochrome P450 1A1 and uridine-diphosphate-glucuronosyltransferase 1A1 allelic polymorphisms on the risk of development and the prognosis of head and neck cancers.
Szanyi I; Ráth G; Móricz P; Somogyvári K; Révész P; Gerlinger I; Orsós Z; Ember I; Kiss I
Eur J Cancer Prev; 2012 Nov; 21(6):560-8. PubMed ID: 22273851
[TBL] [Abstract][Full Text] [Related]
14. Detection of CYP1A1 gene polymorphism using designed RFLP and distributions of CYP1A1 genotypes in Japanese.
Oyama T; Mitsudomi T; Kawamoto T; Ogami A; Osaki T; Kodama Y; Yasumoto K
Int Arch Occup Environ Health; 1995; 67(4):253-6. PubMed ID: 7591186
[TBL] [Abstract][Full Text] [Related]
15. CYP1A1 Ile462Val polymorphism contributes to colorectal cancer risk: a meta-analysis.
Jin JQ; Hu YY; Niu YM; Yang GL; Wu YY; Leng WD; Xia LY
World J Gastroenterol; 2011 Jan; 17(2):260-6. PubMed ID: 21246002
[TBL] [Abstract][Full Text] [Related]
16. [Association of CYP1A1 Ile462Val polymorphisms with susceptibility to small cell lung cancer].
He B; Lin J; Cao L; Wang H; Rao J; Liu Y; Zhang Z
Wei Sheng Yan Jiu; 2014 May; 43(3):393-6, 418. PubMed ID: 24964616
[TBL] [Abstract][Full Text] [Related]
17. CYP1A1, CYP2E1 and GSTM1 genetic polymorphisms. The effect of single and combined genotypes on lung cancer susceptibility in Chilean people.
Quiñones L; Lucas D; Godoy J; Cáceres D; Berthou F; Varela N; Lee K; Acevedo C; Martínez L; Aguilera AM; Gil L
Cancer Lett; 2001 Dec; 174(1):35-44. PubMed ID: 11675150
[TBL] [Abstract][Full Text] [Related]
18. [Relationship between CYP1A1 gene polymorphisms and urinary 1-hydroxypyrene levels in coke oven workers].
Nie JS; Zhang HM; Sun JY; Zeng P; Zhang L; Niu Q
Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi; 2009 May; 27(5):270-5. PubMed ID: 19538838
[TBL] [Abstract][Full Text] [Related]
19. Polymorphisms in CYP1A1 and smoking: no association with breast cancer risk.
Basham VM; Pharoah PD; Healey CS; Luben RN; Day NE; Easton DF; Ponder BA; Dunning AM
Carcinogenesis; 2001 Nov; 22(11):1797-800. PubMed ID: 11698341
[TBL] [Abstract][Full Text] [Related]
20. CYP1A1 and GSTM1 polymorphic genotypes in patients with prostate cancer in a Turkish population.
Aktas D; Hascicek M; Sozen S; Ozen H; Tuncbilek E
Cancer Genet Cytogenet; 2004 Oct; 154(1):81-5. PubMed ID: 15381379
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
